Keppra xr and Complex partial seizures exacerbated - a phase IV clinical study of FDA data

Summary:

Complex partial seizures exacerbated is reported as a side effect among people who take Keppra xr (levetiracetam), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Vimpat, and have Convulsion.

The phase IV clinical study analyzes which people have Complex partial seizures exacerbated when taking Keppra xr. It is created by eHealthMe based on reports of 2,026 people who have side effects when taking Keppra xr from the FDA, and is updated regularly.

What is Keppra xr?

Keppra xr has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 2,272 Keppra xr users. Check the latest studies of Keppra xr.

What is Complex partial seizures exacerbated?

Complex partial seizures exacerbated (type of seizure in epilepsy) is found to be associated with 203 drugs and 246 conditions by eHealthMe. Check the latest studies of Complex partial seizures exacerbated.

On Jul, 10, 2026

2,026 people reported to have side effects when taking Keppra xr.
Among them, 12 people (0.59%) have Complex partial seizures exacerbated.

Could Keppra xr cause Complex partial seizures exacerbated?

Among these 12 people:

How long have people been on Keppra xr when they have Complex partial seizures exacerbated? *

What is the gender of people who have Complex partial seizures exacerbated when taking Keppra xr? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Complex partial seizures exacerbated when taking Keppra xr? *

What are other drugs people take besides Keppra xr? *

What are other side effects people have besides Complex partial seizures exacerbated? *

Drug Ineffective: 4 people, 33.33%
Petit Mal Epilepsy (absence seizure): 3 people, 25.00%
Itching: 3 people, 25.00%
Headache (pain in head): 2 people, 16.67%
Birth Control: 2 people, 16.67%
Rickets (softening of bones): 2 people, 16.67%
Postpartum Sepsis (infection woman after childbirth): 2 people, 16.67%
Postpartum Haemorrhage (bleeding in woman after she has given birth): 2 people, 16.67%
Eye Pain: 2 people, 16.67%
Drowsiness: 1 person, 8.33%

What are the existing conditions these people have? *

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 25.00%
Immunodeficiency: 2 people, 16.67%
Birth Control: 2 people, 16.67%
Thyroid Diseases: 1 person, 8.33%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 8.33%
Pain: 1 person, 8.33%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 8.33%
Hyperthyroidism (over activity of the thyroid gland): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
Heart Disease: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Keppra xr and have Complex partial seizures exacerbated?

- Check whether Complex partial seizures exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Keppra xr:

Keppra xr (2,272 reports)

Browse all side effects of Keppra xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Complex partial seizures exacerbated:

Complex partial seizures exacerbated (203 drugs)

Browse all the conditions that are associated with Complex partial seizures exacerbated:

Complex partial seizures exacerbated (246 conditions)

Related publications that referenced our studies

Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam (the active ingredients of Keppra xr) and Keppra xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.